¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"progressive retinal atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • retinal tacking
    ¸Á¸·¸øÁú
  • rhegmatogenous retinal detachment
    ¿­°ø¸Á¸·¹Ú¸®
  • atrophy
    À§Ãà(Áõ)
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀåÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà, ÇÇÁúÀ§Ãà
  • choroidal atrophy
    ¸Æ¶ô¸·À§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    Áöµµ¸ð¾çÀ§Ãà
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • retinal rod
    ¸Á¸·¸·´ë¼¼Æ÷, ¸Á¸·°£Ã¼
  • retinal tacking
    ¸Á¸·¸øÁú
  • retinal tuft
    ¸Á¸·¼ú
  • atrophy
    ˤ̈
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀ§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà
  • cyanotic atrophy
    û»öÁõÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • progressive idiopathic atrophoderma
    ÁøÇ༺ ¿øÀÎºÒ¸í¼º ÇǺΠÀ§ÃàÁõ
  • progressive lenticular degeneration
    ÁøÇ༺ ·»ÁîÇÙº¯¼º(Áõ)(òäú¼àõ¡­ú·Ü¨àõ(ñø))
  • progressive lingual hemiatrophy
    ÁøÇà(¼º) ¹ÝÃø¼³À§ÃàÁõ
  • progressive lingual hemiatrophy
    ÁøÇ༺ ¹ÝÃø¼³À§ÃàÁõ(òäú¼àõ Úâö°àßê×õêñø)
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ.
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ(òäú¼àõ ò·Û¸ì¶ç½å×ñø)
  • progressive mean
    ´©°¡Æò±Õ(ËÈ˧̰˻).
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´Ù¹ß¼º ¹éÁú³ú(º´)Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´ÙÃÊÁ¡¼º ¹éÁú³úº´Áõ(òäú¼àõ Òýõ¥ïÇàõ ÛÜòõÒàÜ»ñø)
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõÐÉì¶ç½å×ñø).
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõ ì¶ç½å×ñø)
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(òäú¼àõ ÐÉÜ»ñø)
  • progressive myopia
    ÁøÇ༺ ±Ù½Ã(òäú¼àõ ÐÎãÊ) ¾Æµ¿ÀÇ
  • progressive nodular fibrosis of the skin
    ÁøÇ༺ °áÀý ÇǺΠ¼¶À¯Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • progressive ophtalmoplegia
    ÁøÇ༺ ¾È±Ù ¸¶ºñ(òäú¼àõ äÑÐÉØ¦Ýö)
  • progressive pigmentary dermatosis
    ÁøÇ༺ »ö¼Ò¼º ÇǺÎÁõ
  • progressive pigmentary dermatosis
    ÁøÇ༺ »ö¼Ò¼º ÇǺÎÁõ(òäú¼àõ ßäáÈàõ ù«Ý±ñø)
  • progressive resistance
    Á¡ÁõÀúÇ×(ïÂñòî½ù÷).
  • progressive resistance exercise
    Á¡ÁõÀúÇ׿(ïÂñòî½ù÷ê¡ÔÑ).
  • progressive rubella panencephalitis
  • progressive spastic spinal paralysis
    ÁøÇ༺ °æ¼º ô¼ö¸¶ºñ(òäú¼àõÌâàõô±âÐ Ýö).
  • progressive spastic spinal paralysis
    ÁøÇ༺ °æ¼º ô¼ö¸¶ºñ(òäú¼àõ Ìâàõ ô±âÐØ¦Ýö)
  • progressive spinal amyotrophy
    ÁøÇ༺ ô¼ö¼º ±ÙÀ§ÃàÁõ(òäú¼àõô±âÐàõÐÉê×õê ñø).
  • progressive spinal amyotrophy
    ÁøÇ༺ ô¼ö¼º ±ÙÀ§ÃàÁõ(òäú¼àõ ô±âÐàõ ÐÉê×õêñø)
  • progressive subcortical encephalopathy
    ÁøÇ༺ ÇÇÁúÇϳúÀå¾Ö<³úÁõ>(¡­ù«òõù» Òàî¡äô<Òàñø>).
  • progressive subcortical encephalopathy
    ÁøÇ༺ ÇÇÁúÇϳúÀå¾Ö<³úÁõ>(òäú¼àõ ù«òõù»Òàî¡äô<Òàñø>)
  • progressive supranuclear palsy
    ÁøÇ༺ Çٻ󸶺ñ(òäú¼àõú·ß¾ Ýö).
  • progressive supranuclear palsy
    ÁøÇ༺ »óÇÙ¸¶ºñ(Çٻ󸶺ñ)(òäú¼àõ ß¾ú·Ø¦Ýö(ú·ß¾Ø¦Ýö))
  • progressive symmetric erythrokeratodermia
    ÁøÇ༺ ´ëμº È«»ö °¢ÇÇÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CRAD central retinal artery occlusion
CRAO central retinal artery occlusion
CRB chemical, radiological, and biological; congenital retinal blindness
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
CRP chronic relapsing pancreatitis; corneal-retinal potential; coronary rehabilitation program; C-reacti...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PPA Primary Progressive Aphasia
PAL progressive addition lens
PD Progressive Disease
PFIC Progressive Familial Intrahepatic Cholestasis
PMF Progressive Massive Fibrosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • periodontal atrophy
    Ä¡ÁÖ ÅðÃà
  • pontine nuclear atrophy
    ³ú±³ ÇÙÀÇ À§Ãà
  • postinflammatory optic atrophy
    ¿°ÁõÈÄ ½Ã½Å°æ À§Ãà
  • pressure atrophy
    ¾Ð¹Ú À§Ãà
  • reticular atrophy
    ¸Á»ó À§Ãà
  • senile atrophy
    ³ë³â¼º À§Ãà, ³ëÀμº À§Ãà
    ³ªÀ̰¡ µê¿¡ µû¸¥ ¸ðµç Á¶Á÷ÀÇ »ý¸®ÀûÀÎ À§Ãà.
  • Zimmerlin's atrophy
    Áü¸Þ¸¦¸° À§Ãà
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
progressive bacterial synergistic gangrene Undermining ulcer of the skin and subcutaneous tissues, usually following an operation, caused by a synergistic interaction between microaerophilic nonhemolytic streptococci and aerobic haemolytic staphylococci.
Synonym: Meleney's gangrene, progressive bacterial synergistic gangrene.
(05 Mar 2000)
progressive bulbar palsy One of the subgroups of motor neuron disease; a progressive degenerative disorder of the motor neurons of primarily the brainstem, manifested as weakness (and wasting) of the various bulbar muscles, resulting in dysarthria and dysphagia-fluid regurgitation is an outstanding symptom and can cause aspiration; tongue weakness and wasting is usually evident, and often the fasciculation potentials are present in the tongue and facial muscles.
Synonym: glossopalatolabial paralysis, glossopharyngeolabial paralysis.
(05 Mar 2000)
progressive bulbar paralysis Progressive weakness and atrophy of the muscles of the tongue, lips, palate, pharynx, and larynx, usually occurring in later life; most often caused by motor neuron disease.
Synonym: bulbar palsy, bulbar paralysis, Duchenne's disease, Erb disease, glossolabiolaryngeal paralysis, glossolabiopharyngeal paralysis.
(05 Mar 2000)
progressive cataract A cataract in which the opacification process progresses to involve the entire lens.
(05 Mar 2000)
progressive cerebellar tremor <syndrome> An intention tremor beginning in one extremity, gradually increasing in intensity, and subsequently involving other parts of the body.
Synonym: progressive cerebellar tremor.
Facial paralysis, otalgia, and herpes zoster resulting from viral infection of the seventh cranial nerve and geniculate ganglion, a form of juvenile paralysis agitans associated with primary atrophy of the pallidal system.
Synonym: paleostriatal syndrome, pallidal syndrome.
Synonym: Ramsay Hunt's syndrome.
(05 Mar 2000)
progressive cerebral poliodystrophy Familial progressive spastic paresis of extremities with progressive mental deterioration, with development of seizures, blindness and deafness, beginning during the first year of life, and with destruction and disorganization of nerve cells of the cerebral cortex.
Synonym: Alpers disease, Christensen-Krabbe disease, progressive cerebral poliodystrophy.
(05 Mar 2000)
progressive cleavage In fungi, a type of sporulation in which cleavage planes in the cytoplasm first produce protospores and then sporangiospores in a sporangium.
(05 Mar 2000)
progressive emphysematous necrosis <microbiology> A severe form of gangrene (tissue necrosis) caused by Clostridium infection. Also referred to as necrotising subcutaneous infection.
Results in death of the subcutaneous tissues and muscle layers.
See: necrotising fascitis.
(27 Sep 1997)
progressive familial scleroderma A syndrome characterised by calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia; usually due to scleroderma; autosomal dominant form of progressive systemic sclerosis.
(05 Mar 2000)
progressive hypertrophic polyneuropathy A familial type of demyelinating sensorimotor polyneuropathy that begins in early childhood and is slowly progressive; clinically characterised by foot pain and paresthesias, followed by symmetrical weakness and wasting of the distal limbs; one of the causes of stork legs; patients are wheelchair bound at an early age; peripheral nerves are palpably enlarged and non-tender; pathologically, onion bulb formation is seen in the nerves: whorls of overlapping, intertwined Schwann cell processes that encircle bare axons; usually autosomal recessive inheritance.
Synonym: Dejerine's disease, progressive hypertrophic polyneuropathy.
(05 Mar 2000)
progressive lipodystrophy A condition characterised by a complete loss of the subcutaneous fat of the upper part of the torso, the arms, neck, and face, sometimes with an increase of fat in the tissues about and below the pelvis.
Synonym: Barraquer's disease, lipodystrophia progessiva superior, partial lipoatrophy, Simons' disease.
(05 Mar 2000)
progressive massive fibrosis <radiology> Progressive massive fibrosis, silicosis (properly conglomerate nodules, not progressive massive fibrosis), coal worker's pneumoconiosis, density (conglomerate mass) in upper lobe, retracts toward hilum, leaves emphysematous change (bullae) at lung periphery
(12 Dec 1998)
progressive multifocal leukoencephalopathy <radiology> Demyelinating disease due to papovavirus, seen in immunosuppressed hosts: lymphoma, leukaemia, AIDS, TB, sarcoidosis, organ transplant, most prominent in pareito-occipital white matter, NO contrast enhancement
(12 Dec 1998)
progressive muscle relaxation A cognitive-behavioural strategy in which muscles are alternately tensed and then relaxed in a systematic fashion.
(16 Dec 1997)
progressive muscular dystrophy A form of progressive muscular atrophy in which the disease begins in the muscle and not in the spinal centres.
Synonym: Erb atrophy, idiopathic muscular atrophy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á